Cannanda CB2 Wellness: Inhaled Beta-Caryophyllene for Smokers
Researchers at Showa University ran a randomized, double-blind, placebo-controlled trial on active smokers--not trying to make them quit, just measuring what happened to arterial stiffness when they inhaled BCP alongside cigarette smoke. The results were published in a peer-reviewed medical journal in 2023.
Look, you've heard the lecture. Your doctor has told you. Your spouse has told you. The package is screaming at you in big block letters. You know smoking is wrecking your arteries, your lungs, and your odds of seeing your grandkids graduate.
And you've probably tried to quit. Maybe more than once. Patches. Gum. That prescription that gave you weird dreams. Sheer willpower that lasted three weeks before life got hard and the pack came back.
So now you're in the in-between place. Not ready to quit today. Not pretending it's not slowly damaging you. Carrying a quiet anxiety about your cardiovascular system that you don't have a good answer for yet.
Researchers at Showa University in Japan recently ran a clinical trial on smokers, and they didn't try to make them quit. They asked a different question: while a person is still smoking, is there a natural compound that can help protect their arteries from some of the damage?
What Smoking Actually Does to Your Arteries
Every drag delivers nicotine, oxidants, and inflammatory compounds that quietly stiffen your arteries over time. Your blood vessels are supposed to be flexible, expanding and contracting with every heartbeat. Smoking turns them into something more like rigid pipes.
Doctors measure this with brachial-ankle pulse wave velocity (baPWV): how fast your pulse travels through your arteries. The faster it travels, the stiffer your arteries are. The stiffer they are, the higher your risk of heart attack, stroke, and a long list of cardiovascular problems. Smokers have noticeably higher baPWV than non-smokers, and that stiffness is a big part of why smoking shortens life expectancy.
The Clinical Trial: What They Actually Found
Smokers who inhaled Beta-Caryophyllene alongside their cigarettes showed reduced arterial stiffness compared to placebo. The researchers also confirmed BCP was entering the bloodstream through inhalation--it wasn't just sitting in the lungs and being exhaled. Published in Experimental and Therapeutic Medicine, 2023 (PMID: 36588810).
This is not one study standing alone. Two independent research lines, two different methodologies, both pointing in the same direction:
Randomized, double-blind, placebo-controlled. Smokers inhaled BCP alongside cigarette smoke. Result: reduced baPWV, the direct measure of arterial stiffness, compared to placebo. Published: Experimental and Therapeutic Medicine.
Animal study showing inhaled BCP gets incorporated into the wall of the aorta itself and reduces nicotine-induced aortic degeneration via CB2 receptor activation. Published: PMID 36076543.
Why Inhalation Is the Right Route, and Why CB2 Wellness Was Built for It
The Showa University study didn't use BCP capsules or oil swallowed at dinner. It used inhaled BCP delivered alongside cigarette smoke. The route of delivery matters. Inhaled BCP gets into your bloodstream within seconds and circulates through the cardiovascular system. The animal data shows it physically reaches the artery wall. That's a fundamentally different exposure pattern than waiting for digestion.
Cannanda CB2 Wellness was specifically formulated as an inhalable BCP product, a concentrated Beta-Caryophyllene designed to be used either as drops under the tongue or inhaled directly from the bottle, the same fundamental delivery route used in the Japanese trial.
- It is concentrated Beta-Caryophyllene: a food-grade plant terpene designed for sublingual or inhalation use
- It is not a smoking cessation product
- It is not a vape or e-cigarette
- It is not a nicotine replacement therapy
- It contains zero THC, zero CBD, zero nicotine, and zero cannabis-derived compounds
- The single most effective thing any smoker can do for their cardiovascular health is to stop smoking, this product is for the in-between time
- Cardiovascular tissue health and arterial flexibility
- Healthy inflammatory response in vascular tissue
- Oxidative stress management (highly relevant given how oxidative smoking is)
- CB2 receptor activation, increasingly recognized as a protective pathway in vascular tissue
- A healthy stress response
BCP has been the subject of hundreds of peer-reviewed studies. Its CB2 activity was confirmed in research published in the Proceedings of the National Academy of Sciences. The cardiovascular findings are recent additions to a growing body of research.
Where You Could Be in Six Months
Still working on the bigger goal, and you will get there, when you're ready. But in the meantime, you've done the one practical thing you could for the artery wall carrying you through every day. You've added a clinically researched, food-grade plant terpene that supports your cardiovascular tissue right where the damage is happening.
You've given your future self a healthier body to quit with.
That's not a fantasy. That's harm reduction at its most practical.
How to Use CB2 Wellness as a Smoker
100% legal. Zero THC. Zero CBD. Zero nicotine. No prescription required. Ships across North America, Australia, and the UK. Cannanda offers a satisfaction guarantee.
Research references: Saito T et al. "Effects of inhaled β-caryophyllene on vascular stiffness in smokers: A randomized, double-blind, placebo-controlled trial." Experimental and Therapeutic Medicine, 2023 (PMID: 36588810). Supporting research: "Inhaled volatile β-caryophyllene is incorporated into the aortic wall and attenuates nicotine-induced aorta degeneration via a CB2 receptor-dependent pathway" (PMID: 36076543).
